GovChime
Notice ID: cc30712f220748248369bc7368efe7a4Combined Synopsis/Solicitation

FY25 Vaccines for Children

Archived on February 14, 2025. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
1:00 PM UTC−05:00
Posted
January 17, 2025
Notice type
Combined Synopsis/Solicitation
NAICS
325412: Pharmaceutical Preparation Manufacturing
Agency
Department of Health and Human ServicesCENTERS FOR DISEASE CONTROL AND PREVENTION

Notice details

Office
CDC OFFICE OF ACQUISITION SERVICES
Place of performance
Atlanta, GA, 30341
PSC
6505: DRUGS AND BIOLOGICALS
Last updated
Jan 23, 2026

Identifiers

Solicitation number
75D30125R00065
Notice ID
cc30712f220748248369bc7368efe7a4

Description

The Centers for Disease Control and Prevention (CDC) awards contracts to the manufacturers of pediatric vaccines for the purchase of standard commercial pediatric vaccines. Vaccines are one of the most cost-effective ways to prevent disease and reduce healthcare costs. The Vaccine for Children (VFC) program, established pursuant to Section 13631 of the Omnibus Budget Reconciliation Act of 1993 (OBRA 93), guarantees federal support for the purchase and supply of sufficient quantities of vaccine to the States to cover a defined group of children. The program helps assure the implementation of effective immunization practices and proper use of vaccines to achieve higher immunization coverage. Children (18 years-of-age or younger) who qualify for immunization through the VFC purchase program include those who are (1) Medicaid-eligible, (2) without health insurance, (3) American Indian/Alaska native (as defined in Subsection (h)(3) of the OBRA 93), or (4) children with health insurance, which does not cover the cost of vaccines, if they receive their immunizations at a Federally-qualified health center or rural health clinic (as defined by the Social Security Act). Health care providers who agree to certain requirements are eligible through the States to receive free vaccine through this VFC purchase program. The establishment of these contracts provides an opportunity to utilize VFC funds and Section 317 vaccine purchase funds to obtain vaccines at prices below those available in the commercial marketplace. In addition, awardees may opt to purchase additional quantities of vaccine under any resulting contract to provide immunizations for children who are not federally vaccine-eligible children using state and local funds. Offerors for this requirement must be manufacturers of pediatric vaccines in accordance with 42 U.S.C. 1396s. The term "manufacturer" means any corporation, organization, or institution, whether public or private (including Federal, State, and local departments, agencies, and instrumentalities), which manufactures, imports, processes, or distributes under its label any pediatric vaccine. The term "manufacture" means to manufacture, import, process, or distribute a vaccine.

Full description on SAM.gov

Award Overview

No prior contract identified

No matching prior contract was found within an 18-month window using the same agency, NAICS, place-of-performance state, and PSC. This may be a new requirement, or the prior award uses a different classification.

Contacts

Documents

Select documents to download

Showing 3 of 3 items

Document
Source
Agency
Posted Date
File Size
Actions
Combined Synopsis/SolicitationCENTERS FOR DISEASE CONTROL AND PREVENTIONJan 17, 2025-
Combined Synopsis/SolicitationCENTERS FOR DISEASE CONTROL AND PREVENTIONJan 17, 2025-
Combined Synopsis/SolicitationCENTERS FOR DISEASE CONTROL AND PREVENTIONJan 17, 2025-

Lifecycle

Solicitation:75D30125R00065
  1. Combined Synopsis
  1. 3×
    Combined SynopsisCurrentJan 16, 2025

    FY25 Vaccines for Children

    Notice cc30712f220748248369bc7368efe7a4 on SAM.gov

Similar Opportunities

Title
Phase
Deadline

Additional Details

Solicitation Number

75D30125R00065

Archive Date

Feb 14, 2025

Office Address

ATLANTA, GA, 30333